| Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the … C Théry, KW Witwer, E Aikawa, MJ Alcaraz, JD Anderson, ... Journal of extracellular vesicles 7 (1), 1535750, 2018 | 8234 | 2018 |
| Separation, characterization, and standardization of extracellular vesicles for drug delivery applications D Buschmann, V Mussack, JB Byrd Advanced drug delivery reviews 174, 348-368, 2021 | 77 | 2021 |
| Comparing small urinary extracellular vesicle purification methods with a view to RNA sequencing—Enabling robust and non-invasive biomarker research V Mussack, G Wittmann, MW Pfaffl Biomolecular Detection and Quantification 17, 100089, 2019 | 57 | 2019 |
| Impact of long-term storage and freeze-thawing on eight circulating microRNAs in plasma samples PR Matias-Garcia, R Wilson, V Mussack, E Reischl, M Waldenberger, ... PloS one 15 (1), e0227648, 2020 | 53 | 2020 |
| TGFBR2‑dependent alterations of microRNA profiles in extracellular vesicles and parental colorectal cancer cells F Fricke, V Mussack, D Buschmann, I Hausser, MW Pfaffl, J Kopitz, ... International Journal of Oncology 55 (4), 925-937, 2019 | 23 | 2019 |
| On the trail of blood doping—microRNA fingerprints to monitor autologous blood transfusions in vivo V Mussack, G Wittmann, MW Pfaffl American Journal of Hematology 96 (3), 338-353, 2021 | 15 | 2021 |
| MIQE-compliant validation of microRNA biomarker signatures established by small RNA sequencing V Mussack, S Hermann, D Buschmann, B Kirchner, MW Pfaffl Quantitative Real-Time PCR: Methods and Protocols, 23-38, 2020 | 9 | 2020 |
| Description and optimization of a multiplex bead-based flow cytometry method (MBFCM) to characterize extracellular vesicles in serum samples from patients with hematological … L Li, A Görgens, V Mussack, E Pepeldjiyska, AS Hartz, A Rank, J Schmohl, ... Cancer Gene Therapy 29 (11), 1600-1615, 2022 | 6 | 2022 |
| Isolation and characterization of urinary extracellular vesicles for MicroRNA biomarker signature development with reference to MISEV compliance M Reithmair, A Lindemann, V Mussack, MW Pfaffl Extracellular Vesicles in Diagnosis and Therapy, 113-133, 2022 | 5 | 2022 |
| The potential role of serum extracellular vesicle derived small RNAs in AML research as non-invasive biomarker L Li, V Mussack, A Görgens, E Pepeldjiyska, AS Hartz, H Aslan, E Rackl, ... Nanoscale Advances 5 (6), 1691-1705, 2023 | 3* | 2023 |
| A panel of blood-derived miRNAs with a stable expression pattern as a potential pan-cancer detection signature A Sabbaghian, V Mussack, B Kirchner, MLU Bui, MR Kalani, MW Pfaffl, ... Frontiers in Molecular Biosciences 9, 1030749, 2022 | 1 | 2022 |
| The role of microRNAs and extracellular vesicles in the detection of autologous blood doping V Mussack Technische Universität München, 2022 | 1 | 2022 |
| Nucleic Acids| RNA Identification and Quantification via RT-qPCR MW Pfaffl, D Buschmann, V Mussack, B Kirchner, B Berisha Academic Press, 2019 | 1 | 2019 |
| Extracellular vesicle miRNAs drive aberrant macrophage responses in NSAID‐exacerbated respiratory disease F Hartung, P Haimerl, S Schindela, V Mussack, B Kirchner, FDR Henkel, ... Allergy, 2024 | | 2024 |
| Role of EVs as promotors for activation of leukemia-derived dendritic cell (DCleu)-mediated antileukemic immune response against AML-blasts L Lin, A Görgens, V Mussack, E Pepeldjiyska, A Hartz, H Aslan, E Rackl, ... | | 2023 |
| Uptake and effects of polystyrene nanoplastics in comparison to non-plastic silica nanoparticles on small intestine cells (IPEC-J2) ARD Binder, V Mussack, B Kirchner, MW Pfaffl Ecotoxicology and Environmental Safety 262, 115147, 2023 | | 2023 |
| The potential role of extracellular vesicle-derived small RNAS in AML research as non-invasive biomarker L Li, V Mussack, A Goergens, E Pepeldjiyska, AS Hartz, H Aslan, E Rackl, ... JOURNAL FOR IMMUNOTHERAPY OF CANCER 10, A24-A25, 2022 | | 2022 |
| Role of Exosomes as Promotors or Biomarkers To Study Activation of Leukemia-derived Dendritic Cells (DCLEU)-mediated Antileukemic Activation of Adaptive and Innate Immune … L Li, V Mussack, E Pepeldjiyska, A Hartz, A Rank, C Schmid, E Oezkaya, ... BONE MARROW TRANSPLANTATION 55 (SUPPL 1), 576-576, 2020 | | 2020 |
| P01. 11 Role of exosomes as promotors or biomarkers to study activation of leukemia-derived dendritic cells (DCleu)-mediated antileukemic activation of adaptive and innate … L Li, V Mussack, E Pepeldjiyska, A Hartz, A Rank, C Schmid, E Özkaya, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 2), 2020 | | 2020 |
| Nucleic Acids| RNA Identification and Quantification via Next Generation Sequencing D Buschmann, B Kirchner, V Mussack, MW Pfaffl Academic Press, 2019 | | 2019 |
